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Objective.WereportedaveryrarecaseofmetastaticCrohn’sdiseaseinvolvingtheretro-auricularregion.Method.Acaser eportand
a review of literature concerning metastatic Crohn’s disease. Results. Metastatic Crohn’s disease is an uncommon extraintestinal
cutaneous manifestation of Crohn’s disease and a very rare case involving the retro-auricular region is reported here. Given
the limited existing literature little is known about this condition. The skin lesions appear to have a predilection for the lower
trunk and genitalia regions. There is no clear association with the severity of Crohn’s disease and in some cases, the cutaneous
lesions predate the onset of gastrointestinal Crohn’s disease. Treatment with immune-modulating medications together with the
antitumour necrosis factor monoclonal antibody therapy appears to oﬀer the best chance of remission. Conclusion. By reporting
this interesting and rare condition we also hope to highlight the importance of considering underlying chronic systemic disorders,
such as Crohn’s disease, when presented with skin lesions resistant to simple local treatments.
Copyright © 2009 J. H. Chuah et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Metastatic cutaneous Crohn’s disease is a rare manifestation
of Crohn’s disease. Its hallmark features include the presence
of cutaneous granulomatous lesions noncontiguous with the
gastrointestinal tract or ﬁstulae [1]. The clinical appearance
can vary and biopsy is required to conﬁrm the diagnosis.
We report a very rare case of metastatic Crohn’s disease
aﬀecting the ear in a man with longstanding Crohn’s disease.
We aim to highlight the need for clinical suspicion of
systemic diseases that may present as a localised ear lesion,
in particular, the rare entity of metastatic Crohn’s disease.
2.CaseReport
A 43-year-old man with an 18 years history of Crohn’s
disease developed a severe erythematous and exudative skin
lesion in the right postauricular cleft region. Prominent
purulentdischargeandmicroabscessessuggestedaninfective
lesion. The patient had recently completed a course of the
therapeutic drug inﬂiximab, a monoclonal antibody for
tumour necrosis factor (TNF), which is a key inﬂammatory
agent in systemic inﬂammatory conditions. Gastroenterol-
ogists were concerned that the skin lesion was an infective
complication of the new therapeutic regimen due to a
possible immunosuppressive action. Several antibacterial
agents were used with no clinical beneﬁt, and the patient was
then referred to the ENT department for a second opinion.
Concurrently, the patient had a recurrence of severe perineal
Crohn’s disease and warranted further course of inﬂiximab.
However, given the issue of possible association with the
skin lesion, the treatment decision was deferred pending
resolution of the skin condition.
Initial ENT examination excluded an otitis externa
causing local inﬂammation from overspill onto the adjacent
skin area. Appearance of the skin lesion was in keeping with
either an infection or severe eczematous inﬂammation. A
skin swab for culture was taken and triadcortyl ointment
applied. During the initial consultation, the patient com-
plained of a similar lesion starting in the umbilicus region.
The swab result reported heavy growths of beta-hemolytic
streptococcus and Staphylococcus aureus with moderate
anaerobes. Triple therapy with ﬂucloxacillin, erythromycin,
and metronidazole proved to be ineﬀective. During this
period, there was gradual deterioration of the lesion, which
prompted a biopsy of the periauricular skin lesion. The
pathologist reported the biopsy to represent a chronic
noncaseating granulomatous lesion consistent with a diag-
nosis ofmetastatic Crohn’s disease (please refer pathology
report).2 International Journal of Otolaryngology
Figure 1: Skin biopsy (x10 objective, haematoxylin, and eosin
stain) showing a dermal chronic inﬂammatory cell inﬁltrate with
noncaseating epithelioid and giant cell granulomas. Although there
are no pathognomonic features, this is consistent with metastatic
Crohn’s disease.
Subsequently, with dermatology advice, treatment with
high-dose betnovate cream, oral steroids, and inﬂiximab
resulted in rapid remission of the skin condition (both the
postaural and umbilical areas) and the perineal Crohn’s
disease.
3. Pathology Report
Histological haematoxylin and eosin sections (Figure 1)
demonstrated chronic inﬂammation of the dermis with
admixed epithelioid and giant cell granulomas. Schau-
mann’s bodies were seen within the giant cells. There
was no caseation, and elastic ﬁbres were absent from the
granulomas. Furthermore, there was an absence of fungi,
staining for acid and alcohol fast bacilli were negative, and
birefringent foreign bodies were not seen. These appear-





as seen in the aﬀected bowel segments of patients with
Crohn’sdisease,butisphysicallyseparatedfromthegastroin-
testinal tract [2]. This condition is distinct from other more
well-characterized cutaneous manifestations which include
pyoderma gangrenosum, erythema nodosum, polyarteritis
nodosa, and epidermolysis acquisita. Although the estimated
incidence of cutaneous manifestation of Crohn’s disease
varies widely between 2% and 44% [3], true metastatic
cutaneous Crohn’s disease is exceedingly rare.
Metastatic Crohn’s disease does not appear to have any
distinct relationship with the severity of the Crohn’s bowel
disease [3], and indeed may even precede gastrointestinal
involvement [3]. However, there is a suggestion in the
limited literature available that there may be an association
with perianal Crohn’s disease [3]. Of the reported cases
of metastatic Crohn’s disease involvement primarily of the
lower limbs and trunk regions with a predilection for
skin fold areas and genitalia has been described [4]. There
has been only one reported case of facial involvement
documented more than 30 years ago.
Todate,giventherarityofthecondition,thereisnogold-
standard therapy for metastatic Crohn’s disease [2]. The use
of systemic and topical steroids, antibiotics, and immuno-
suppressive agents such as azathioprine, sulfasalazine, and
methotrexate has been described with variable success
[4]. The use of Inﬂiximab, an antitumour necrosis factor
monoclonal antibody, as one of the latest treatment options
has been described in a few case reports to be more
eﬀective in maintaining disease remission, especially with
repetitive administration and when used concomitantly with
other more mainstream therapies [5–7]. Further evidence
is needed to substantiate this. However, given their recent
introduction to clinical use, in addition to a better evidence
for clinical eﬃcacy in various disorders, new side eﬀects may
also become apparent with time and should be carefully
evaluated.
In the case being presented, the possibility of an unusual
diagnosis for the skin lesion was raised by several features:
the sudden onset of postauricular rash in a gentleman with
no previous ear or skin condition; the aggressive nature of
thepurulentrash;theobservedresistancetoseveralcommon
treatments used including multiple antimicrobial agents and
topical steroid cream. The diagnosis of the rare cutaneous
Crohn’s disease was ﬁrst suggested by the biopsy demon-
strating chronic granulomatous inﬂammation in a patient
known to be suﬀering from active Crohn’s disease. Biopsies
demonstrating chronic granulomatous inﬂammation of the
skin require the pathologists to consider other and more
common disorders including sarcoidosis, tuberculosis and
fungal or parasitic infections, foreign body granulomas,
and annular elastocystic granuloma. Histological analysis
failed to demonstrate any of the pathognomonic features
of the other granulomatous conditions. The diagnosis of
metastatic Crohn’s was further supported by the rapid
remission both of the skin rash and perineal Crohn’s
disease in response to treatment with high-dose local
steroid cream, oral steroids, and concomitant inﬂiximab
infusion.
Despite its rarity, a meticulous evaluation including a
thorough history and examination, and biopsy in cases
unresponsive to simple measures, together with a high index
of clinical suspicion in those with an established diagnosis
or presenting with concomitant clinical features of Crohn’s
disease, may provide early diagnosis of this skin condition
which can be disﬁguring and emotionally distressing to the
patient. The diagnosis of metastatic Crohn’s disease may be
relatively easier in patients with established Crohn’s disease
comparedtothosecaseswheretheskinlesionsprecedebowel
involvement. In the latter cases, diagnosis by biopsy should
then lead to appropriate counseling about the diagnosis of
Crohn’s disease and the future onset of the more signiﬁcant
bowel disease.
We hope by reporting this rare and interesting case that
we may highlight the need to consider systemic diseases, in
particular, chronic inﬂammatory conditions such as Crohn’s
disease, as causes of skin lesions of the ear and face that are
unresponsive to simple treatments.International Journal of Otolaryngology 3
5. Summary
(i) Metastatic Crohn’s disease is an uncommon cuta-
neous manifestation of Crohn’s disease.
(ii) Metastatic Crohn’s lesions have a predilection for the
skin fold, limbs, and trunk.
(iii) Metastatic Crohn’s involving ear is extremely rare.
(iv) To date, there is no gold standard treatment for
metastatic Crohn’s disease.
(v) Treatment with repetitive administration of Inﬂix-
imab together with other mainstream therapies is
promising in maintaining disease remission.
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